Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma
British Journal of Dermatology · 2024
DOI: 10.1093/bjd/ljae092 ↗Kurz gefasst
Editorial in der Zeitschrift British Journal of Dermatology, 2024. Verfasst von Simone Ribero und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy. Hauptthemen laut MEDLINE: Melanoma, Skin Neoplasms, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.
Themen: Patientensicherheit
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
ORCID-Profile: Gabriele Roccuzzo
Zitieren
APA
Ribero, S., Quaglino, P., & Roccuzzo, G. (2024). Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma. British Journal of Dermatology. https://doi.org/10.1093/bjd/ljae092
Vancouver
Ribero S, Quaglino P, Roccuzzo G. Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma. British Journal of Dermatology. 2024. doi:10.1093/bjd/ljae092
BibTeX
@article{Ribero2024,
author = {Ribero, Simone and Quaglino, Pietro and Roccuzzo, Gabriele},
title = {Unveiling cutaneous adverse events and prognosis in immunotherapy for melanoma and squamous cell carcinoma},
journal = {British Journal of Dermatology},
year = {2024},
doi = {10.1093/bjd/ljae092}
}
EUVIMED